Literature DB >> 2452203

Activation of murine natural killer cells and macrophages by 8-bromoguanosine.

G C Koo1, M E Jewell, C L Manyak, N H Sigal, L S Wicker.   

Abstract

It has been shown that 8-bromoguanosine (8-BrGuo) activates T and B cells, but the underlying mechanism of this effect is not clear. We found that it also activates NK cells and macrophages by induction of IFN production. Culturing spleen cells with 8-BrGuo for 16 to 18 h induced cytotoxic activity to YAC cells. The cytotoxic cells expressed Qa-5, asialo-Gm-1, and NK-1.1 Ag. Similarly, preincubation of peptone-elicited peritoneal macrophages with 8-BrGuo induced macrophage cytolytic activity to P815 cells in an 18-h assay. Anti-IFN antibodies to IFN-alpha -beta and -gamma abolished these inductive events. Furthermore, elimination of asialo-Gm-1+ cells reduced the responses of NK and macrophages to 8-BrGuo, indicating that these cells possibly produce the IFN. We conclude from these observations that one biologic effect of 8-BrGuo is due to IFN production.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2452203

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  4 in total

1.  Broad-spectrum in vivo antiviral activity of 7-thia-8-oxoguanosine, a novel immunopotentiating agent.

Authors:  D F Smee; H A Alaghamandan; H B Cottam; B S Sharma; W B Jolley; R K Robins
Journal:  Antimicrob Agents Chemother       Date:  1989-09       Impact factor: 5.191

2.  7-Allyl-8-oxoguanosine (loxoribine) inhibits the metastasis of B16 melanoma cells and has adjuvant activity in mice immunized with a B16 tumor vaccine.

Authors:  B L Pope; J Sigindere; E Chourmouzis; P MacIntyre; M G Goodman
Journal:  Cancer Immunol Immunother       Date:  1994-02       Impact factor: 6.968

3.  NKG2D-RAE-1 receptor-ligand variation does not account for the NK cell defect in nonobese diabetic mice.

Authors:  Lisa M Maier; Sarah K Howlett; Kara M Rainbow; Jan Clark; Joanna M M Howson; John A Todd; Linda S Wicker
Journal:  J Immunol       Date:  2008-11-15       Impact factor: 5.422

4.  Reevaluation of NOD/SCID Mice as NK Cell-Deficient Models.

Authors:  Miao Miao; Henry Masengere; Guang Yu; Fengping Shan
Journal:  Biomed Res Int       Date:  2021-11-10       Impact factor: 3.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.